Chapla Agarwal

University Of Colorado Denver

$5,180,994

Attributed

$5,180,994

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $706.4K · FY2005–12

$1M$750K$500K$250K$0

'05

'06

'07

'08

'09

'10

'11

'12

Funding mix

By agency

NIH$5,180,994 · 2

By mechanism

R01$5,180,994 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Colorado Denver

Same institution · by research overlap

Al Marcus$2,267,015
Rajesh Agarwal$27,337,251
Dennis J Ahnen$2,064,751

Others in their field

Top investigators on “Apoptosis”

David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
Jay A Nelson · Oregon Health & Science University$45,942,124
John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
John A Tainer · Scripps Research Institute$30,637,655
Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167

Research focus

ApoptosisBiologicalCellsCancer EtiologyFeedingBaseCancer CellCell Cycle ProgressionCessation Of LifeApoptoticActivin (Grape Seed Extract)United StatesSourceStagingPhytochemicalNeoplasticProanthocyanidinsChemopreventive AgentDietConsumptionIn VivoCell Cycle ArrestCell CycleEpithelial